Pinsent Masons advises the UK government on purchase of further 60m doses of Covid-19 vaccines
10 May 2021 | 09:36 am |
Multinational law firm Pinsent Masons has successfully advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.
The team at Pinsent Masons was led by Life Sciences transactions partner Allistair Booth and included Andy Cornforth, Niki Ruprai, Robert Sherville-Payne and Aaron Hope.
Commenting on the agreement, Allistair Booth, lead partner at Pinsent Masons said:
"This is an important agreement. Access to 60m doses of that vaccine in time for an autumn revaccination programme will hopefully play a key role in protecting the NHS and the most vulnerable people of the UK.
"We are proud to have worked with the UK government on securing this agreement for such an important vaccine at such a crucial time".
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises shareholders of roda Computer GmbH on the sale of their shares to MilDef Group
Multinational law firm Pinsent Masons has advised the shareholders of roda computer GmbH on the sale of their shares to the Swedish company MilDef Group AB (publ).
Pinsent Masons hires key construction disputes expert in the Middle East
Multinational law firm Pinsent Masons welcomes Rena L. Scott to the partnership in the Middle East.
Pinsent Masons partners with Xapien to launch the world’s first large language AI tool for Anti-Money Laundering compliance
Multinational law firm Pinsent Masons has partnered with AI SaaS company, Xapien, to launch the world’s first large language model artificial intelligence (AI) tool that will transform the global Anti-Money Laundering (AML) compliance industry.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons announces new leadership for Global IP Group and Life Sciences
Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.
Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London
Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.
Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture
Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]